Edition:
United Kingdom

DaVita Inc (DVA.N)

DVA.N on New York Stock Exchange

53.71USD
20 Mar 2019
Change (% chg)

$-0.20 (-0.37%)
Prev Close
$53.91
Open
$53.96
Day's High
$54.54
Day's Low
$52.86
Volume
405,490
Avg. Vol
430,784
52-wk High
$79.02
52-wk Low
$48.25

Chart for

About

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations,... (more)

Overall

Beta: 0.98
Market Cap(Mil.): $11,437.58
Shares Outstanding(Mil.): 191.20
Dividend: --
Yield (%): --

Financials

  DVA.N Industry Sector
P/E (TTM): 9.19 26.99 32.54
EPS (TTM): 6.51 -- --
ROI: 9.66 6.63 13.82
ROE: 26.53 10.49 15.25

DaVita unit to pay $270 million to resolve Medicare payments probe

A medical care unit of DaVita Inc has agreed to pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.

01 Oct 2018

UPDATE 2-DaVita unit to pay $270 mln to resolve Medicare payments probe

Oct 1 A medical care unit of DaVita Inc has agreed to pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.

01 Oct 2018

DaVita resolves U.S. probe into Medicare payments for $270 mln

Oct 1 A medical care unit of DaVita Inc will pay $270 million to resolve claims it provided inaccurate information about patients that caused Medicare Advantage plans operated by private insurers to obtain inflated payments from the government.

01 Oct 2018

Earnings vs. Estimates